My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
PURDUE NATIONAL OPIOIDS SETTLEMENT
Clerk
>
Contracts / Agreements
>
P
>
PURDUE NATIONAL OPIOIDS SETTLEMENT
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
9/24/2025 1:45:31 PM
Creation date
9/24/2025 1:45:07 PM
Metadata
Fields
Template:
Contracts
Company Name
PURDUE NATIONAL OPIOIDS SETTLEMENT
Contract #
A-2025-160
Agency
City Attorney's Office
Council Approval Date
9/16/2025
Expiration Date
1/1/1900
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
34
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
Docusign Envelope ID:F617E359-4OD9-46EO-BD71-OF5OB4798B26 <br /> However, in no event shall more than one-third (5% out of the 15%) be used for <br /> litigation-related fees and expenses. <br /> D. Provision for State Back-Stop Agreement <br /> On August 6, 2021, Judge Dan Polster of the U.S. District Court,Northern District of Ohio, <br /> Eastern Division, issued an order(ECF Docket Number 3814) ("MDL Fees Order") in the <br /> National Prescription Opiate Litigation (MDL No. 2804) "cap[ping] all applicable contingent fee <br /> agreements at 15%."Private counsel representing Plaintiff Subdivisions should seek its <br /> contingency fees and costs from the Local Government Costs and Expenses Fund pursuant to the <br /> Governing Documents, and if applicable,the Attorney Fee Fund or Cost Funds under the <br /> settlement agreements with other Opioid Defendants. <br /> A Plaintiff Subdivision may separately agree to use up to one-third(5%out of the 15%) of its <br /> share of the CA Subdivision Fund to pay for fees or costs incurred by its contingency-fee counsel <br /> ("State Back-Stop Agreement"), pursuant to Exhibit R of the GESA and the MDL Fees Order, so <br /> long as: (1) such payments, together with any payments to contingency-fee counsel from the <br /> Local Government Costs and Expenses Fund related to such Plaintiff Subdivision, do not exceed <br /> 15% of a Plaintiff Subdivision's total gross recovery under this Agreement; and (2)Plaintiff <br /> Subdivision certifies that any payments made under a State Back-Stop Agreement will be made <br /> in accordance with the 95% Opioid Abatement use requirements under Section 5.02(a) of the <br /> GESA and Section 4.01(f)(i) of the MSA. Before seeking fees or litigation costs and expenses <br /> from a State Back-Stop Agreement,private counsel representing Plaintiff Subdivisions must first <br /> seek contingency fees and costs from the Local Government Costs and Expenses Fund funded <br /> pursuant to the Governing Documents. Further,private counsel may only seek reimbursement for <br /> litigation fees and costs that have not previously been reimbursed through prior settlements or <br /> judgments. <br /> To effectuate a State Back-Stop Agreement pursuant to this section, an agreement in the form of <br /> Appendix 2 may be entered into by a Plaintiff Subdivision,private counsel, and the California <br /> Office of the Attorney General. The California Office of the Attorney General shall, upon the <br /> request of a Plaintiff Subdivision, execute any agreement executed by a Plaintiff Subdivision and <br /> its private counsel if it is in the form of Appendix 2. The California Office of the Attorney <br /> General will also consider requests from Plaintiff Subdivisions to execute and enter into <br /> agreements presented in other forms. <br /> For the avoidance of doubt, this Agreement does not require a Plaintiff Subdivision to request or <br /> enter into a State Back-Stop Agreement, and no State Back-Stop Agreement shall impose any <br /> duty or obligation on the State of California or any of its agencies or officers, including without <br /> limitation the Attorney General. <br /> RI 0 <br /> 6 0 <br />
The URL can be used to link to this page
Your browser does not support the video tag.